Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2586184 in chronic plaque psoriasis
NCT01782664Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of solcitinib in plaque psoriasis, sponsored by GSK. Started Mar 2013; status: completed.
02
Drugs
solcitinib
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01782664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01782664.